Abstract: The use of the single nucleotide polymorphism (SNP) of the ADAMTS4 gene for the identification of cardiovascular and peripheral vascular disorders or of an increased risk for developing cardiovascular and peripheral vascular disorders in a biological sample taken from an individual to be examined; the use of ADAMTS4 for identifying substances active in preventing and/or treating cardiovascular and peripheral vascular disorders and methods for doing so.

Abstract: The present invention refers to a method for the in vitro or in vivo diagnosis of cardiovascular diseases, in particular high blood pressure, stenosis, vessel occlusion and/or other thrombotic events, wherein the nucleotide at position 950 of a nucleic acid coding for the human ARK2 protein or the amino acid at position 298 of the human ARK2 protein of a sample of a person is determined as well as to the use of ARK2 for the development and/or production of a medicament for treating a cardiovascular disease.

Abstract: The present invention refers to human EGLN2 variants having at position 58 of the amino acid sequence a serine or a leucine and their use in the prevention or treatment of thromboembolic or coronary heart diseases, in particular stroke, prolonged reversible ischemic neurological deficit (PRIND), transitoric ischemic attack (TIA), myocardial infarction and/or early myocardial infarction.

Abstract: The present invention refers to a method for the in vitro diagnosis of thromboembolic and/or coronary heart diseases, wherein the nucleotide at position 470 of a nucleic acid coding for the human EGLN2 protein or the amino acid at position 58 of the human EGLN2 protein of a sample of a person is determined.

Abstract: The present invention refers to the use of the Mst protein or a nucleotide sequence coding for the Mst protein for the treatment of a thromboembolic disorder and to a method of screening a modulator of the Mst protein or the nucleotide sequence coding for the Mst protein.

Abstract: The use of the single nucleotide polymorphism (SNP) at position ?(97) of the GIP gene for the identification of a cardiovascular disease or of an increased risk for developing a cardiovascular disease in a biological sample taken from an individual to be examined.

Abstract: The present invention refers to a method of diagnosis of a predisposition to develop thrombotic disease, to test systems and their use for the diagnosis of a predisposition to develop thrombotic disease, to a P2X1 promoter variant and its use for screening for an anti-thrombotic agent, and to methods for identifying an individual that can be prophylactically or therapeutically treated with an anti-thrombotic agent, or for adapting a therapeutic or prophylactic dose of an anti-thrombotic agent.

Abstract: A method for remote diagnosis and central error evaluation of decentralized electronic devices (1) with an integrated telecommunications device (3) includes the steps of storing information about malfunctions of a decentralized electronic device (1) in a diagnosis memory (6) of the electronic device (1); making a telecommunications connection of the electronic device (1) with a central error evaluation station (7), controlled by the user of the electronic device (1); transmitting error data from the diagnosis memory (6) to the central error evaluation station (7); and evaluating the error data in the central error evaluation station (7).

Abstract: A receiver for a radio broadcast signal, in particular a car radio, and a method for receiving a radio broadcast signal, including a signal decoder for decoding an audio signal contained in the radio broadcast signal in encoded form, and/or for decoding a data signal contained in the radio broadcast signal in encoded form, the signal decoder being operable so that the encoded signal is only decoded, when the signal decoder obtains an external authentication signal, which is received via an external transmission path that is different from the transmission path of the radio broadcast signal.

Abstract: The present invention relates to LIMK-1, a LIMK-1-analogue or LIMK-1 ligand for the binding to GPIIb and/or activation or inhibition of GPIIb/IIIa downstream signaling, for the production of a medicament for the prevention or treatment of a thrombus formation or blood clotting disease, methods of screening a LIMK-1 analogue or a LIMK-1 ligand and a method for producing a medicament for the treatment of a thrombus formation or blood clotting disease.

Abstract: A method for remote diagnosis and central error evaluation of decentralized electronic devices (1) with an integrated telecommunications device (3) has the following steps:

Abstract: Compounds of the formula I are suitable for producing pharmaceuticals for the prophylaxis and therapy of diseases in which high blood platelet aggregations occur.

Abstract: Compounds of the formula I 1

Abstract: The digital filter includes a first multiplier (2) receiving an input signal, an adder (3) connected to the first multiplier (2) to receive its output signal, a delay element (6) connected to the adder (3) to receive its output signal, a second multiplier (7) connected between the delay element (6) and a second input of the adder (3) in a feedback branch, a device (16) for supplying either of two values (K1.1, K1.2) of a first multiplier coefficient to the first multiplier (2) and a device (17) for supplying either of two values (K2.1, K2.2) of a second multiplier coefficient to the second multiplier (7). The second one (K2.2) of the two values of the second multiplier coefficient is advantageously 0, while the second one (K1.2) of the first multiplier coefficient values is equal to a quotient of a predetermined first one of the first multiplier coefficient values and a difference between one and a predetermined first one of the second multiplier coefficient values.

Abstract: The method for obtaining the quality signal includes multiplying a digital multiplex signal (MPX) by respective reference carrier signals mutually phase shifted by 90.degree. to each other, but otherwise equal, to form a pair of mixed signals (Imr1,Imr2); multiplying the mixed signals (Imr1, Imr2) by respective correction signals (G38c,G38s) to form a pair of corrected mixed signal (Ims1,Ims2); separately multiplying the digital multiplex signal (MPX) by each of two reference pilot signals mutually shifted in phase by 90.degree.

Abstract: In a circuit for deriving at least one quality signal that is dependent on the quality of a received signal, where the received signal is demodulated, a first auxiliary signal which is dependent on the field strength, and a second or further auxiliary signal, are derived from the demodulated signal. The auxiliary signal and the second or further auxiliary signal are combined to derive the quality signal.

Abstract: A radio receiver is provided having digital signal processing, a first and a second auxiliary signal derived from a received stereo multiplex signal, the first auxiliary signal being dependent upon the existence of signal components, whose frequency lies above the fundamental frequency range of the stereo multiplex signal, and the second auxiliary signal being dependent upon the symmetry of the sidebands of the stereo subcarrier. The first and the second auxiliary signal are combined to form an interference signal indicating the existence of interference. At least one control signal is derived from the interference signal to influence the audio signals acquired by decoding the stereo multiplex signal.

Abstract: The circuit arrangement includes a first low-pass filter (2) for filtering an input signal (H3) proportional to the strength of a received radio signal; a second low-pass filter (3) for filtering the input signal (H3); a first weighting circuit (7) for weighting the first low-pass filter output signal with first coefficients to form a first weighted output signal; a circuit device for forming a masking signal for reducing stereo channel isolation from the first weighted output signal; a second weighting circuit (5) for forming a second weighted output signal weighted with second coefficients from the first low-pass filter output signal or the second low-pass filter output signal according to a switching signal (DD2) indicative of interference in the audio signals; a switch device (4) for selecting the first low-pass filter output signal for weighting in the second weighting circuit means (5) when no interference is indicated by the switching signal (DD2) and the second low-pass filter output signal for weight

Abstract: A circuit arrangement for recognizing adjacent channel interference in a stereo radio receiver, in which a stereo multiplex signal is present. An adjacent channel interference signal is obtained as a function of a direct voltage portion of the stereo multiplex signal and as a function of the spectral components of the stereo multiplex signal above 60 kHz.

Abstract: A circuit arrangement for deriving the signal indicating noise in a received stereo multiplex signal, wherein the stereo multiplex signal is present as a digital signal with a first sampling rate that is substantially higher than twice the upper limit of the useful frequency range of the stereo multiplex signal, and the received stereo multiplex signal is passed through a low-pass filter. The low-pass filtered signal and the received stereo multiplex signal are subjected to decimation to a second sampling rate, which is higher than twice the upper limit of the useful frequency range of the stereo multiplex signal. The two stereo multiplex signals with the second sampling rate are subtracted from one another.